Skye Bioscience, Inc. Shareholders' Equity
Skye Bioscience, Inc. (SKYE) had Shareholders' Equity of -$497.31 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$497.31K.
- 2026-03-31: Stockholders' Equity Attributable to Parent $9.01M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $20.02M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $32.84M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$497.31K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $9.01M 10-Q · filed 2026-08-14 |
| 2025-12-31 | $20.02M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $32.84M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $43.68M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $59.25M 10-Q · filed 2026-08-14 |
| 2024-12-31 | $68.15M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $75.80M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $72.81M 10-Q · filed 2025-11-10 |
| 2024-03-31 | $78.88M 10-Q · filed 2025-11-10 |
| 2023-12-31 | -$2.13M 10-K · filed 2026-03-10 |
| 2023-09-30 | $1.70M 10-Q · filed 2024-11-07 |
| 2023-06-30 | -$7.79M 10-Q · filed 2024-11-07 |
| 2023-03-31 | -$4.78M 10-Q · filed 2024-11-07 |
| 2022-12-31 | -$3.01M 10-K · filed 2025-03-20 |
| 2022-09-30 | -$3.28M 10-Q · filed 2023-11-14 |
| 2022-06-30 | -$301.82K 10-Q · filed 2023-11-14 |
| 2022-03-31 | $2.97M 10-Q · filed 2023-11-14 |
| 2021-12-31 | $5.86M 10-K · filed 2024-03-22 |
| 2021-09-30 | $8.26M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $2.27M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $2.48M 10-Q · filed 2022-11-14 |
| 2020-12-31 | $450.79K 10-K · filed 2023-03-31 |
| 2020-09-30 | $1.85M 10-Q · filed 2021-11-10 |
| 2020-06-30 | -$3.09M 10-Q · filed 2021-11-10 |
| 2020-03-31 | -$1.70M 10-Q · filed 2021-11-10 |
| 2019-12-31 | $548.06K 10-K · filed 2022-03-28 |
| 2019-09-30 | -$16.40M 10-Q · filed 2020-11-06 |
| 2019-06-30 | -$11.64M 10-Q · filed 2020-11-06 |
| 2019-03-31 | -$27.86M 10-Q · filed 2020-11-06 |
| 2018-12-31 | -$15.56M 10-K · filed 2021-03-02 |
| 2018-09-30 | -$10.16M 10-Q · filed 2019-11-14 |
| 2018-06-30 | -$8.25M 10-Q · filed 2019-11-14 |
| 2018-03-31 | -$5.75M 10-Q · filed 2019-11-14 |
| 2017-12-31 | -$3.57M 10-K · filed 2020-03-23 |
| 2017-09-30 | -$3.23M 10-Q · filed 2017-11-14 |
| 2017-06-30 | -$2.93M 10-Q · filed 2017-08-11 |
| 2017-03-31 | -$2.88M 10-Q · filed 2017-05-12 |
| 2016-12-31 | -$2.91M 10-K · filed 2019-03-14 |
| 2016-09-30 | -$2.38M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$1.62M 10-Q · filed 2016-08-12 |
| 2016-03-31 | -$2.37M 10-Q · filed 2016-05-13 |
| 2015-12-31 | -$892.20K 10-K · filed 2018-03-19 |
| 2015-09-30 | -$594.29K 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$861.01K 10-Q · filed 2015-08-14 |
| 2015-03-31 | -$338.36K 10-Q · filed 2015-05-13 |
| 2014-12-31 | -$453.55K 10-K · filed 2017-03-10 |
| 2014-09-30 | $776.29K 10-Q · filed 2014-11-14 |
| 2014-07-31 | $81.14K 10-Q · filed 2014-09-15 |
| 2014-04-30 | $73.38K 10-Q · filed 2014-06-05 |
| 2014-01-31 | $87.00K 10-Q · filed 2014-03-17 |
| 2013-12-31 | -$182.15K 10-K · filed 2016-03-21 |
| 2013-10-31 | $83.38K 10-Q · filed 2014-09-15 |
| 2013-07-31 | $64.75K 10-Q · filed 2013-09-16 |
| 2013-04-30 | $65.59K 10-Q · filed 2013-06-27 |
| 2012-12-31 | -$61.75K 10-K · filed 2015-03-27 |
| 2012-10-31 | $38.56K 10-Q · filed 2014-09-15 |
| 2011-10-31 | $25.95K 10-K · filed 2014-01-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |